NEWMARK

Cantor Fitzgerald Relief Fund

Todd Perman, Garth Hogan and the entire Newmark Global Healthcare Services (GHS) team, support Howard Lutnick and Cantor Fitzgerald in the spirit of giving to individuals and families in need. Especially, during a time of crisis. We have all contributed to the Cantor Relief Fund and encourage everyone to join.

The Cantor Fitzgerald Relief Fund (www.cantorrelief.org), a 501(c)(3) not-for-profit, was founded on September 14, 2001, with a $1 million personal donation from Cantor Fitzgerald Chairman and CEO, Howard W. Lutnick. Since then, the fund has raised and distributed approximately $304 million to victims of terrorism, natural disasters and emergencies, direct service charities, and wounded members of our military.

View website

temp-post-image

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our
Brochure

Sign Up for Our Newsletter

VIEW 2022 HEALTHCARE OUTLOOK